Orca Pharmaceuticals
Abingdon · Founded 2012
About Orca Pharmaceuticals
Orca Pharmaceuticals is a new biotechnology startup focusing on treating autoimmune diseases. Funding is from BioMotiv, a Cleveland, Ohio based therapeutics accelerator affiliated with The Harrington Project, and the New York University Innovation Venture Fund. The company, located in Oxford UK, is based on technology developed by inventors from New York University (NYU) in collaboration with the founders in the United Kingdom.
Company Facts
- Founded: 2012
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.3M
- Last round: Series Unknown (Apr 2014)
- Website: http://orcapharmaceuticals.com
- Phone: 44 1235 841 542
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/orca-pharmaceuticals-2267831 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.